Form 8-K - Current report:
SEC Accession No. 0001140361-24-030447
Filing Date
2024-06-18
Accepted
2024-06-18 09:29:02
Documents
15
Period of Report
2024-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20031301_8k.htm   iXBRL 8-K 26205
2 EXHIBIT 99.1 ef20031301_ex99-1.htm EX-99.1 16461
6 image0.jpg GRAPHIC 411086
  Complete submission text file 0001140361-24-030447.txt   749208

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20240618.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240618_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240618_pre.xml EX-101.PRE 16050
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20031301_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241050370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)